Sign In
Buy IRWD
$3.24
-0.0400 (-1.22%)
At Close: Jun 03, 2026
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025
04:03pm, Wednesday, 26'th Nov 2025
Ironwood Pharmaceuticals (IRWD) remains undervalued despite a failed $1bn Vectiv Bio acquisition and subsequent stock plunge, with Linzess providing strong recurring revenue. IRWD's apraglutide Phase
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of “Hold” by Brokerages
03:46am, Saturday, 22'nd Nov 2025
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD - Get Free Report) has been assigned a consensus rating of "Hold" from the eight analysts that are currently covering the company, MarketBeat reports. One
Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3?
11:30am, Friday, 21'st Nov 2025
Ironwood gains momentum as rising U.S. demand for Linzess drives strong profit growth during the third quarter.
Connor Clark & Lunn Investment Management Ltd. Grows Position in Ironwood Pharmaceuticals, Inc. $IRWD
04:36am, Monday, 17'th Nov 2025
Connor Clark and Lunn Investment Management Ltd. raised its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) by 48.3% during the second quarter, according to its most recent disclosure with the
Acadian Asset Management LLC Buys 3,904,498 Shares of Ironwood Pharmaceuticals, Inc. $IRWD
03:16am, Friday, 14'th Nov 2025
Acadian Asset Management LLC increased its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) by 147.6% during the undefined quarter, according to its most recent filing with the Secu
IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock?
11:41am, Thursday, 13'th Nov 2025
Ironwood's 110% monthly surge follows upbeat third-quarter results and raised 2025 outlook, powered by increasing Linzess demand.
IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock Soars
11:01am, Tuesday, 11'th Nov 2025
Ironwood posts a stellar third-quarter beat with higher revenues and raises 2025 outlook on Linzess-driven strength.
Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass Estimates
09:25am, Monday, 10'th Nov 2025
Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.02 per share a year ago.
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
07:05am, Monday, 10'th Nov 2025
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and
Google's AI chip 'Ironwood' takes on Nvidia
12:23pm, Thursday, 06'th Nov 2025
CNBC's MacKenzie Sigalos joins 'Money Movers' with the latest details on Google's new custom chip efforts and how they stack up against Nvidia.
Focus Partners Advisor Solutions LLC Raises Stock Holdings in Ironwood Pharmaceuticals, Inc. $IRWD
04:03am, Monday, 03'rd Nov 2025
Focus Partners Advisor Solutions LLC increased its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) by 284.6% during the second quarter, according to its most recent filing with the
Ironwood Stair & Rail Inc. Recognised With 2025 Consumer Choice Award for Stairs and Railings in Southern Alberta
08:10am, Friday, 24'th Oct 2025
CALGARY, AB / ACCESS Newswire / October 24, 2025 / Ironwood Stair & Rail Inc., a company built on craftsmanship and passion, has been recognised with the 2025 Consumer Choice Award in the Stairs and R
Ironwood Pharmaceuticals, Inc. $IRWD Shares Sold by KLP Kapitalforvaltning AS
03:07am, Wednesday, 22'nd Oct 2025
KLP Kapitalforvaltning AS trimmed its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) by 12.2% during the second quarter, according to its most recent filing with the Securities and E
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery
12:01pm, Tuesday, 14'th Oct 2025
Innovation is at its peak in the Zacks Medical-Drugs industry. AKBA, IRWD, PYXS, CRDL and PSTV may prove to be good additions to one's portfolio.
Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term
10:51am, Tuesday, 14'th Oct 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
